Service Hotline +86 400-068-7188

China Drug Procurement and Agency Industry Report 2014-2018, Market Prospect and Investment Strategic Planning

China Drug Procurement and Agency Industry Report 2014-2018, Market Prospect and Investment Strategic Planning

China Drug Procurement and Agency Industry Report 2014-2018, Market Prospect and Investment Strategic Planning

A must-have for enterprise medium to long-term strategic planning

Without deep industry knowledge, it will be difficult to gain any return

English Version:USD7900

Including: Paper back + Electronic Copy + Invoice

Customer Hotline:+86 755 - 82925195 / 82925295

Free Hotline:+86 400-068-7188After-sales Hotline: +86 755-33013088

The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area

Special Statement

We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product. Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase. Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"前瞻"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!

* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!

  • Table of Contents

  • Content Summary

China Drug Procurement and Agency Industry Report 2014-2018, Market Prospect and Investment Strategic Planning

Reporting core values

Drug procurement of medical institutions is an essential part of health care institutions to carry out health services. With social progress and the continuous development of science and technology, drug procurement has become an activity of great strategic significance for medical institutions.

Main Contents of report

Drug procurement of medical institutions is an essential part of health care institutions to carry out health services. With social progress and the continuous development of science and technology, drug procurement has become an activity of great strategic significance for medical institutions. In many of China's medical institutions, drug income takes a large proportion in total operating income. Therefore, drug procurement model has important significance for medical institutions to improve efficiency and ensure quality of medicines and reduce the burden on patients' medication.

At the beginning of 2013, Beijing, Shanghai and Guangdong representing China's advanced productive forces have indicated that they will carry out reforms on current drug procurement mode. Bidding has features of being open, just and fair and is widely considered to be the priority for procurement. However, due to different tendering organizations, openness, fairness and impartiality of bidding are also different, which forms their own distinctive ways of bidding.

This report is based on long-term market tracking information by Forward Intelligence on drug procurement and agency industry. It uses international scientific analysis models and analyses comprehensively and accurately the structure system from the overall height of the industry for you. This report mainly analyzes development background and market environment of China's drug procurement and agency industry, status quo of development of China's drug procurement and agency industry; together with international advanced drug procurement models and offers insights and opinions on development of China's drug procurement and agency industry. Meanwhile, based on first-hand market data of the whole industry in the past five years, it can allow you to fully and accurately grasp market trends and development trends of the whole industry.

The greatest feature of this report is forward-looking and timeliness. Based on the development path and years of practical experience, it makes careful analysis and prediction of the future development trends of drug procurement and agency industry. It is a rare quality for drug procurement platforms, research units, bidding agency, pharmaceutical production and distribution companies and investment companies to accurately understand the latest developments of the industry, grasp market opportunities, make the right business decisions and clear corporate directions. It is also the industry's first on comprehensive and systematic analysis of drug procurement and agency industry

This report will help drug procurement platforms, research units, bidding agency, pharmaceutical production and distribution companies and investment companies accurately understand the latest developments of the industry and early detect blank points of industry market, opportunities, growth and profitability points ...... it will help prospectively grasp unmet market needs and trends of the industry and become a good advantage for sustainable development, effectively avoid the investment risks from the industry, more efficiently consolidate or expand appropriate strategic target markets, and firmly grasp the initiative authority in market competition.

For any special needs, please contact us.Customize Your Report

  • The National Bureau of Statistics Foreign-related investigation Permission

  • National Innovation Company and Dual Software Certified Enterprise

  • The only DRC desginated Enterprise of the Industry Yearbook

  • National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation

  • Guangdong Province Enterprise of Observing Contract and Valuing Credit

Qianzhan Industrial Research Institute· The leading company of China Business Consulting

  • 01

    Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.

  • 02

    Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.

  • 03

    Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.

  • 04

    Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.

  • 05

    Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.

  • 06

    Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.

  • 07

    Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.

  • 08

    Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.

What Else do We Offer

Contact Us

Shenzhen Headquarter

Free Hotline:+86 400-068-7188

Customer Hotline:+86 755 - 82925195 / 82925295

Email Address:service@qianzhan.com

3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China

Shanghai Office

Location:Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China